Skip to main content

Cellular Oncology

Ausgabe 6/2023

Inhalt (24 Artikel)

Open Access Review

Iron metabolism in colorectal cancer: a balancing act

Diogo Estêvão, Miguel da Cruz-Ribeiro, Ana P. Cardoso, Ângela M. Costa, Maria J. Oliveira, Tiago L. Duarte, Tânia B. da Cruz

Review

Predictive genomic biomarkers of therapeutic effects in renal cell carcinoma

Weijie Yan, Naiqiao Hou, Junhua Zheng, Wei Zhai

Review

Roles of NRF2 in DNA damage repair

Jiale Li, Chang Xu, Qiang Liu

Review

Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma

Yiwen Chen, Yuhang Zhou, Ziyang Yan, Peilin Tong, Qiang Xia, Kang He

Research

TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma

Banglun Pan, Zengbin Wang, Yuxin Yao, Xiaoling Ke, Shuling Shen, Weihong Chen, Xiaoxia Zhang, Jiacheng Qiu, Xiaoxuan Wu, Nanhong Tang

Research

Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma

Xiaotong Yang, Zhengyan Zhang, Xuqing Shen, Junyi Xu, Yawen Weng, Wei Wang, Jing Xue

Open Access Research

Methionine-producing tumor micro(be) environment fuels growth of solid tumors

Alexis A. Vega, Erin A. Marshall, Avery J. C. Noonan, Fernando Sergio Leitao Filho, Julia Yang, Greg L. Stewart, Fraser D. Johnson, Emily A. Vucic, Michelle E. Pewarchuk, Parag P. Shah, Brian F. Clem, Corey Nislow, Stephen Lam, William W. Lockwood, Steven J. Hallam, Janice M. Leung, Levi J. Beverly, Wan L. Lam

Research

LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing

Huan Deng, Jingwang Gao, Bo Cao, Ziyu Qiu, Tian Li, Ruiyang Zhao, Hanghang Li, Bo Wei

Research

Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer

Guangyu Chen, Yueze Liu, Dan Su, Jiangdong Qiu, Junyu Long, Fangyu Zhao, Jinxin Tao, Gang Yang, Hua Huang, Jianchun Xiao, Taiping Zhang, Yupei Zhao

Research

Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia

Yanxin Chen, Zhengjun Wu, Lingyan Wang, Minhui Lin, Peifang Jiang, Jingjing Wen, Jiazheng Li, Yunda Hong, Xiaoyun Zheng, Xiaozhu Yang, Jing Zheng, Robert Peter Gale, Ting Yang, Jianda Hu

Open Access Research

Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer

Shuying He, Wen Song, Shudan Cui, Jiating Li, Yonghong Jiang, Xueqing Chen, Liang Peng

Research

Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK

Weihua Liu, Yu Zhao, Zhongfeng Liu, Guangji Zhang, Huantong Wu, Xin Zheng, Xihe Tang, Zhiguo Chen

Research

Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex

Qiqi Shi, Bo Yu, Yingwen Zhang, Yi Yang, Chenxin Xu, Mingda Zhang, Guoyu Chen, Fei Luo, Bowen Sun, Ru Yang, Yanxin Li, Haizhong Feng

Research

CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis

Siting Cao, Yali Yin, Huijuan Hu, Shubin Hong, Weiman He, Weiming Lv, Rengyun Liu, Yanbing Li, Shuang Yu, Haipeng Xiao

Research

Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition

Yu’e Liu, Shu Zhao, Yi Chen, Wencong Ma, Shiping Lu, Le He, Jie Chen, Xi Chen, Xiaoling Zhang, Yufeng Shi, Xuan Jiang, Kaijun Zhao

Open Access Research

Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters

Yufeng Li, Minkang Tan, Shengnan Sun, Elena Stea, Baoxu Pang

Research

Survivin degradation by bergenin overcomes pemetrexed resistance

Xiaoying Li, Qi Liang, Li Zhou, Gaoyan Deng, Yeqing Xiao, Yu Gan, Shuangze Han, Jinzhuang Liao, Ruirui Wang, Xiang Qing, Wei Li

Research

Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer

Ao Tian, Tingyu Wu, Yanshuang Zhang, Jiachen Chen, Jianjun Sha, Weiliang Xia

Correction

Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity

Yi Yang, Siqi Wang, Jiaoyang Cai, Jianwei Liang, Yingwen Zhang, Yangyang Xie, Fei Luo, Jingyan Tang, Yijin Gao, Shuhong Shen, Haizhong Feng, Yanxin Li

Open Access Retraction Note

Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling

Tian-Hao Li, Bang-Bo Zhao, Cheng Qin, Yuan-Yang Wang, Ze-Ru Li, Hong-Tao Cao, Xiao-Ying Yang, Xing-Tong Zhou, Wei-Bin Wang

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …